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Abstract
Parkinson’s Disease (PD) is a neurodegenerative disease that currently does
not have a cure. In order to facilitate disease management and reduce the speed of
symptom progression, early diagnosis is essential. The current clinical, diagnostic
approach is to have radiologists perform human visual analysis of the degeneration
of dopaminergic neurons in the substantia nigra region of the brain. Clinically,
dopamine levels are monitored through observing dopamine transporter (DaT)
activity. One method of DaT activity analysis is performed with the injection
of an Iodine-123 fluoropropyl (123I-FP-CIT) tracer combined with single photon
emission computerized tomography (SPECT) imaging. The tracer illustrates the
region of interest in the resulting DaTscan SPECT images. Human visual analy-
sis is slow and vulnerable to subjectivity between radiologists, so the goal was to
develop an introductory implementation of a deep convolutional neural network
that can objectively and accurately classify DaTscan SPECT images as Parkin-
son’s Disease or normal. This study illustrates the approach of using a deep
convolutional neural network and evaluates its performance on DaTscan SPECT
image classification.
The data used in this study was obtained through a database provided by the
Parkinson’s Progression Markers Initiative (PPMI). The deep neural network in
this study utilizes the InceptionV3 architecture, 1st runner up in the 2015 Ima-
geNet Large Scale Visual Recognition Competition (ILSVRC), as a base model.
A custom, binary classifier block was added on top of this base. In order to ac-
count for the small dataset size, a ten fold cross validation was implemented to
evaluate the model’s performance.
∗justin.quan@generationse.com
†jean.su@generationse.com
1
ar
X
iv
:1
90
9.
04
14
2v
1 
 [e
es
s.I
V]
  9
 Se
p 2
01
9
1 INTRODUCTION
Parkinson’s Disease (PD) is a neurodegenerative disease that is currently without a
cure. Early diagnosis of PD has been recognized to help with treatment, reducing the
severity of symptoms, and providing an improved quality of life for those who suffer
from PD [1, 2]. Clinical studies over the years have helped to develop our understand-
ing of the etiology of PD. Clinically, PD is characterized by the loss and degeneration
of dopaminergic neurons in the substantia nigra brain region, resulting in the signifi-
cant loss of dopamine production [3, 4]. Booth (2015) explains a widely used method
to monitor dopaminergic neurons. Dopamine transmission is regulated by dopamine
transporters (DaT), which are densely populated within the substantia nigra region.
Analysis of DaT function through the use of an Iodine-123 fluoropropyl (123I-FP-CIT)
tracer and Single Photon Emission Tomography (SPECT) imaging in the substantia
nigra, specifically the striatum, region of the brain (putamen and caudate structures),
is currently among the recognized diagnosis tools for early PD detection [5]. The
standard practice for DaT SPECT image classification requires human visual analysis
performed by radiologists. Unfortunately, this process is not only time consuming but
also vulnerable to subjectivity and variability between observers.
Deep learning has become a fast growing field of machine learning. The success and
popularity of deep learning can be attributed to factors such as advancements in central
processing units and graphics processing units, increased availability of large amounts
of data, and developments of learning algorithms [6]. The popularity of using deep
convolutional neural networks (CNN) for medical image classification has been on the
rise and have led to some interesting fields of research [7, 8, 9, 10].
The motivation behind this study is to build upon the growing list of applications
of deep learning in medical image analysis. The goal of this study is to implement
an introductory pipeline using a deep CNN that is able to efficiently, accurately and
objectively classify DaTscan SPECT images as PD or non-PD.
2 METHODS
2.1 PPMI Data Collection
Data used in this study was retrieved from a database provided by the Parkinson’s Pro-
gression Markers Initiative (PPMI). PPMI is an observational clinical study to gather
and verify progression markers in PD. The aim of the PPMI study is to create a com-
prehensive set of clinical, imaging and biosample data that can be used to identify
biomarkers of PD progression [11].
The dataset that was collected for this study contains 659 unique patient DaT SPECT
images. These images belong to one of two classes: PD (n=449) and non-PD (n=210).
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To ensure the model is trained on a set of unique subjects and tested on strictly unseen
data, there are no images from follow-up patient visits within the dataset.
2.2 Image Preprocessing
Raw 123I-FP-CIT SPECT images were acquired at PPMI imaging centers following their
protocol [12]. These raw images underwent reconstruction and preprocessing. The data
has been normalized and aligned to the Montreal Neurologic Institute (MNI) space, one
of the accepted standard coordinate systems used for image registration. Each DaT
SPECT is finally presented as a 3D volume in the shape of 91 x 109 x 91.
With limitations in system memory capacity, this study uses the ImageDataGenerator
class from the Keras deep learning library. The ImageDataGenerator is able to load
small batches of images on the fly, directly from their respective directories (train,
validation and test) using the flow from directory method. As the ImageDataGenerator
cannot load volumetric Dicoms and currently does not support custom generators, all
the DaT SPECT images were converted into png format. Each DaT SPECT image
consists of a 3D volume of 91 slices. After reviewing the methods of image preprocessing
from other studies [13, 14, 15] and visual analysis of each slice, it was decided that slices
40-42 appeared to illustrate the areas of interest with the highest pixel intensity. In
order to keep each data image a unique subject and follow the 3-channel input format
for the InceptionV3 model, the 3 slices were concatenated, creating a single 3-channel
(RGB) image. Slice 40, 41, and 42 made up the RGB channels respectively.
To make use of the small dataset, the images underwent augmentations via a series
of transformations. The model does not see the same image twice, which reduces the
chance of the model overfitting on the training data. Data augmentation allows deep
learning to be performed with a small dataset by artificially increasing the size of the
dataset through the creation of modified and transformed copies. The augmentation
ranges were small since SPECT scan images follow a protocol in order to prevent any
discrepancies in alignment between scans. Data augmentations were done on the fly,
just prior to being progressively loaded to the network. This is performed using the
ImageDataGenerator class, provided by the Keras deep learning library. Training data
underwent width shifts, height shifts, horizontal flipping and brightness augmenta-
tions.
2.3 Dataset K-fold Split
The dataset of 659 unique patient DaT SPECT images were split into 10 folds to be
used for k-fold cross validation. Each one of the images were randomly placed into
one of the 10 folds while ensuring that the ratio of classes was kept the same for each
fold. As the dataset does not perfectly split into 10, the outcome was 9 folds consisting
of 66 DaT SPECT images (21 control and 45 PD) and one fold of 65 DaT SPECT
images (21 control and 44 PD). Each unique fold was used once as a validation dataset,
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while the remaining 9 folds comprised the training dataset. The split ratio of training
and validation from the entire dataset was 9:1 respectively. For 9 iterations, there
were 593 training images and 66 validation images. The 10th iteration consists of 594
training images and 65 validation images. The mean of the validation loss and validation
accuracies among the 10 iterations was used to evaluate performance. The purpose for
using 10-fold cross validation was to select high level hyperparameters before running
a final model on test data.
2.4 Neural Network Architecture
This study implements a deep CNN using the Keras neural network library that is
running on top of a TensorFlow backend. Since the dataset is on the smaller side
(n=659), this study utilized transfer learning of a pre-trained model and defined a
custom, binary classifying block. The pre-trained model used for transfer learning was
InceptionV3 [16]. InceptionV3 was selected as it was one of the notable finalists in
the 2015 ImageNet Large Scale Vision Recognition Competition (ILSVRC) [17]. The
InceptionV3 model has learned features from ImageNet’s large visual database [18].
The classifying block consists of a 2D global average pooling layer taking the base
model’s output as its input, followed by a dense layer with ReLU activation, followed
by a dropout layer, and a final dense layer with sigmoid activation. This combined
model was compiled using the Adam optimizer with an initial learning rate of 10−3 and
a step decay function that gradually decreased the learning rate until it reached a final
learning rate of 10−6. The loss function used was binary crossentropy and the metric
used to analyze the performance of the model was accuracy. Each model of the ten-fold
cross validation was trained over 500 epochs with a batch size of 16.
3 RESULTS
3.1 K-fold Cross Validation Performance Evaluation
The K-fold cross validation performed 10 iterations of training and validating a model.
Each iteration used a unique fold as the validation dataset. The validation loss and
validation accuracy results for each iteration are presented in Table 1 below. The test
scores were then used to calculate a mean validation accuracy and loss. Because the
sample sizes of data was not consistent for one of the folds, the validation loss and
accuracies were weighted when calculating the mean. Although the results show that
the training and validation accuracies are close, the validation loss is notably greater
than the training loss among all the models. This generally hints that the models may
have been overfitting on the training data. Iterations of adjustments to the dropout
level were made, but the difference between loss values remain significant. This suggests
that the validation dataset size may be the cause.
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Fold Train Loss Train Accuracy Val Loss Val Accuracy
1 0.0088 1.0000 0.0848 0.9800
2 0.0108 1.0000 0.0459 0.9800
3 0.0968 0.9584 0.1729 0.9400
4 0.0148 0.9966 0.1395 0.9800
5 0.0603 0.9635 0.1180 0.9600
6 0.0341 0.9736 0.1591 0.9600
7 0.0033 1.0000 0.1178 0.9600
8 0.0033 1.0000 0.2117 0.9600
9 0.0049 1.0000 0.1985 0.9600
10 0.0029 1.0000 0.0821 0.9796
Weighted
Mean 0.0240
0.9890
(± 0.0161) 0.1329
0.9645
(± 0.0128)
Table 1: Ten fold cross validation results.
3.2 Final Model
The final architecture and hyperparameters that were obtained from the 10-fold cross
validation were used for the final model. The original dataset of 659 DaT SPECT
images were randomly split in a 80:20 ratio into a training dataset (n=527) and a
testing dataset (n=132) respectively. Both datasets were sorted into sub directories by
their class and loaded into the model using the flow from directory() method from the
ImageDataGenerator class. The training and testing dataset maintain the same ratio
of the two classes, 30% control and 70% PD. The training images underwent the same
augmentations and ranges as they were fed into the model. The model was trained over
500 epochs with a batch size of 16. The learning rate was initialized at 10−3 and ended
at 10−6 through a gradual step decay.
From the predictions of 132 test images, 88 were true positives, 1 was a false positive, 42
were true negatives, and 1 was a false negative. This produced a sensitivity of 0.9888, a
specificity of 0.9767 and a precision of 0.9888. The results were plotted on a precision-
recall (PR) curve and a receiver operating characteristic (ROC) curve. The area under
the PR curve was 0.9967 and the area under the ROC curve was 0.9909.
Test Accuracy 0.9848 PR auc 0.9967
Test Loss 0.0656 ROC auc 0.9909
True Positive 88 True Negative 42
False Positive 1 False Negative 1
Sensitivity 0.9888 Specificity 0.9767
Table 2: Performance results of final model.
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Performance measures were calculated using the following formulas:
Sensitivity =
TruePositive
TruePositive + FalseNegative
Specificity =
TrueNegative
TrueNegative + FalsePositive
Precision =
TruePositive
TruePositive + FalsePositive
(a) PR curve (b) ROC curve
Figure 1: (a) PR curve with an area under the curve value of 0.9967. (b) ROC curve
with an area under the curve value of 0.9909.
(a) False Positive (b) False Negative
Figure 2: Two incorrect predictions made by the final model. Images presented are
3-channel (RGB) images with slices 40, 41, 42 concatenated.
6
4 DISCUSSION
There are a few limitations to this study. The first being the small dataset size and
imbalance of class data. To maintain subject uniqueness, subsequent visit data were
filtered out. As neural network models are sensitive to data used in training, a small
dataset means that each specific example will have a larger impact on the model’s
classification skill. A small testing dataset will likely lead to an optimistic, high variance
estimation in the final model’s performance.
The second limitation was the clinical, labeling of the DaTscan SPECT volumes used
in this study. As there currently isn’t a definitive diagnostic test for PD, neural network
models require radiologists to accurately label the volumes as normal vs PD. This means
the data is still vulnerable to subjectivity of the human evaluations.
The third limitation is that selective slices were used rather than the entire volumetric
image. This creates a selection bias by potentially ignoring important information
found in the adjacent slices. Due to limitations of the system memory capacity, images
were progressively loaded and augmented in small batches on the fly by using the
ImageDataGenerator.
The fourth limitation of this study is that the dataset consists of subjects from a similar
age group. The model cannot be generalized as it has only been trained and tested on
this specific age range. It is also prevalent for individuals in this age range to have other
mental health conditions which could affect the same region of interest and therefore
affect the DaTscan SPECT images .
Although there are still limitations, this study has shown that there is potential to
develop a skillful model that can distinguish between normal and PD patients with
little data. From the results obtained, there is potential that deep neural networks can
be used for accurate classification of Dicom images and that DaT SPECT images can
be a viable input for training a machine learning model.
5 CONCLUSION
The purpose of this study was to implement an introductory pipeline that uses a deep
convolutional neural network to classify DaTscan SPECT images in order to distinguish
between normal subjects and those with Parkinson’s Disease. Although the evaluated
performance of this deep neural network model was favorable, with only one case of false
positive and false negative respectively, it is likely that these results were optimistically
swayed due to the small dataset size and imbalance of class data. Incorporating a larger
dataset and modifications to input an entire volumetric image, the architecture of this
study and its procedures can be useful with further research in this topic.
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